Selexis CHO Cells in Suspension-1

Advanced Gene Technologies

With more than 210 granted patents, innovation is at the heart of Selexis' technologies and procedures that allow us to safely generate high-expressing and stable cell lines in as little as 8-12 weeks.

Selexis SGE® (Selexis Genetic Elements)

Selexis Genetic Elements are proprietary epigenetic DNA-based elements that boost protein expression by controlling the dynamic organization of chromatin around the recombinant gene integration sites. The SGEs facilitate opening of the chromatin and stabilization of the transgene integration, which in turn allows for higher and sustained expression of recombinant proteins, even with multi-gene integrations.

  • Facilitated opening of chromatin
  • Enhanced transcription
  • Stabilization of transgene integration
  • Sustained multigene expression

SUREtech Vectors

Selexis SUREtech Vectors are proprietary vectors that are designed around Selexis Genetic Elements to ensure stable integration of a transgene into the host chromosome, ease of DNA cloning of the target gene into the vector backbone, and efficiency of transfection across a wide range of mammalian cell lines.

  • Ease of DNA cloning of the gene of interest into the vector backbone
  • Efficient and stable integration of the gene of interest into the host chromosome

SUREfection Procedures

Selexis SUREfection Procedures have been optimized to ensure optimal transfection efficiencies. This procedure usually leads to > 80% of cells being transfected.